File:Subgroup analyses of the risks of incident postacute COVID-19 composite neurologic outcomes compared with the contemporary control cohort.webp
From Wikimedia Commons, the free media repository
Jump to navigation
Jump to search
Size of this PNG preview of this WEBP file: 800 × 495 pixels. Other resolutions: 320 × 198 pixels | 640 × 396 pixels | 1,024 × 634 pixels | 1,280 × 793 pixels | 2,120 × 1,313 pixels.
Original file (2,120 × 1,313 pixels, file size: 162 KB, MIME type: image/webp)
File information
Structured data
Captions
Summary
[edit]DescriptionSubgroup analyses of the risks of incident postacute COVID-19 composite neurologic outcomes compared with the contemporary control cohort.webp |
English: "Composite outcomes consisted of cerebrovascular disorders (ischemic stroke, TIA, hemorrhagic stroke and cerebral venous thrombosis), cognition and memory (memory problems and Alzheimer’s disease) disorders, disorders of the peripheral nerves (peripheral neuropathy, paresthesia, dysautonomia and Bell’s palsy), episodic disorders (migraine, epilepsy and seizures, and headache disorders), extrapyramidal and movement disorders (abnormal involuntary movements, tremor, Parkinson-like disease, dystonia, myoclonus), mental health disorders (major depressive disorders, stress and adjustment disorders, anxiety disorders, and psychotic disorders), musculoskeletal disorders (joint pain, myalgia and myopathy), sensory disorders (hearing abnormalities or tinnitus, vision abnormalities, loss of smell and loss of taste), other neurologic or related disorders (dizziness, somnolence, Guillain–Barré syndrome, encephalitis or encephalopathy and transverse myelitis) and any neurologic outcome (incident occurrence of any neurologic outcome studied). Outcomes were ascertained 30 days after the COVID-19-positive test until the end of follow up. COVID-19 cohort (n = 154,068) and contemporary control cohort (n = 5,638,795). Adjusted HRs (dots) and 95% (error bars) CIs are presented. The dashed line marks a HR of 1.00; lower limits of 95% CIs with values greater than 1.00 indicate significantly increased risk." |
Date | |
Source | https://www.nature.com/articles/s41591-022-02001-z |
Author | Authors of the study: Evan Xu, Yan Xie & Ziyad Al-Aly |
Licensing
[edit]This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 07:51, 25 October 2022 | 2,120 × 1,313 (162 KB) | Prototyperspective (talk | contribs) | Uploaded a work by Authors of the study: Evan Xu, Yan Xie & Ziyad Al-Aly from https://www.nature.com/articles/s41591-022-02001-z with UploadWizard |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
Structured data
Items portrayed in this file
depicts
22 September 2022
166,296 byte
1,313 pixel
2,120 pixel
image/webp
469458ea758e9cab31a1cf61c215e065b93e4ac1
Hidden category: